Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression

RT @FrontImmunol: New Research: Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppr…

New Research: Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression: Transplant tolerance in the absence of long-term immunosuppression has been an elusive goal for solid organ… https://t.co/wLpgy

RT @J_Powell_Lab: if you need some non-COVID-19 reading, check out our latest in @FrontImmunol on using metabolic inhibitor therapy in comb…

RT @J_Powell_Lab: if you need some non-COVID-19 reading, check out our latest in @FrontImmunol on using metabolic inhibitor therapy in comb…